How the Interventionalists Can Improve the Outcomes of Coronary Artery Bypass Grafting
Main Article Content
Abstract
N/A
Article Details
How to Cite
BUCH, Ashesh N.; FERGUSON JR, T Bruce.
How the Interventionalists Can Improve the Outcomes of Coronary Artery Bypass Grafting.
Medical Research Archives, [S.l.], v. 12, n. 7, july 2024.
ISSN 2375-1924.
Available at: <https://esmed.org/MRA/mra/article/view/5421>. Date accessed: 05 aug. 2024.
doi: https://doi.org/10.18103/mra.v12i7.5421.
Section
Research Articles
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
1. Thuijs D, Kappetein AP, Serruys PW, et al. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial. Lancet. Oct 12 2019;394(10206):1325-1334. doi:10.1016/s0140-6736(19)31997-x
2. Farkouh ME, Domanski M, Sleeper LA, et al. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med. Dec 20 2012;367(25):2375-84. doi:10.1056/NEJMoa1211585
3. Giustino G, Serruys PW, Sabik JF, 3rd, et al. Mortality After Repeat Revascularization Following PCI or CABG for Left Main Disease: The EXCEL Trial. JACC Cardiovasc Interv. Feb 10 2020;13(3):375-387. doi:10.1016/j.jcin.2019.09.019
4. Maron DJ, Hochman JS, Reynolds HR, et al. Initial Invasive or Conservative Strategy for Stable Coronary Disease. N Engl J Med. Apr 9 2020;382(15):1395-1407. doi:10.1056/NEJMoa1915922
5. Esper RB, Farkouh ME, Ribeiro EE, et al. SYNTAX Score in Patients With Diabetes Undergoing Coronary Revascularization in the FREEDOM Trial. J Am Coll Cardiol. Dec 11 2018;72(23 Pt A):2826-2837. doi:10.1016/j.jacc.2018.09.046
6. Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. Apr 12 2007;356(15):1503-16. doi:10.1056/NEJMoa070829
7. Parisi AF, Folland ED, Hartigan P. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators. N Engl J Med. Jan 2 1992;326(1):10-6. doi:10.1056/nejm199201023260102
8. Spertus JA, Jones PG, Maron DJ, et al. Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease. N Engl J Med. Apr 9 2020;382(15):1408-1419. doi:10.1056/NEJMoa1916370
9. Samadashvili Z, Sundt TM, 3rd, Wechsler A, et al. Multiple Versus Single Arterial Coronary Bypass Graft Surgery for Multivessel Disease. J Am Coll Cardiol. Sep 10 2019;74(10):1275-1285. doi:10.1016/j.jacc.2019.06.067
10. Pu A, Ding L, Shin J, et al. Long-term Outcomes of Multiple Arterial Coronary Artery Bypass Grafting: A Population-Based Study of Patients in British Columbia, Canada. JAMA Cardiol. Nov 1 2017;2(11):1187-1196. doi:10.1001/jamacardio.2017.3705
11. Gaudino M, Benedetto U, Fremes S, et al. Association of Radial Artery Graft vs Saphenous Vein Graft With Long-term Cardiovascular Outcomes Among Patients Undergoing Coronary Artery Bypass Grafting: A Systematic Review and Meta-analysis. Jama. Jul 14 2020;324(2):179-187. doi:10.1001/jama.2020.8228
12. Gaudino M, Chadow D, Rahouma M, et al. Operative Outcomes of Women Undergoing Coronary Artery Bypass Surgery in the US, 2011 to 2020. JAMA Surgery. 2023;158(5):494-502. doi:10.1001/jamasurg.2022.8156
13. Tonino PA, De Bruyne B, Pijls NH, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. Jan 15 2009;360(3):213-24. doi:10.1056/NEJMoa0807611
14. van Nunen LX, Zimmermann FM, Tonino PA, et al. Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial. Lancet. Nov 7 2015;386(10006):1853-60. doi:10.1016/s0140-6736(15)00057-4
15. Sels JW, Tonino PA, Siebert U, et al. Fractional flow reserve in unstable angina and non-ST-segment elevation myocardial infarction experience from the FAME (Fractional flow reserve versus Angiography for Multivessel Evaluation) study. JACC Cardiovasc Interv. Nov 2011;4(11):1183-9. doi:10.1016/j.jcin.2011.08.008
16. Puymirat E, Cayla G, Simon T, et al. Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction. N Engl J Med. Jul 22 2021;385(4):297-308. doi:10.1056/NEJMoa2104650
17. Al-Lamee RK, Shun-Shin MJ, Howard JP, et al. Dobutamine Stress Echocardiography Ischemia as a Predictor of the Placebo-Controlled Efficacy of Percutaneous Coronary Intervention in Stable Coronary Artery Disease: The Stress Echocardiography-Stratified Analysis of ORBITA. Circulation. Nov 11 2019; doi:10.1161/ circulationaha.119.042918
18. Al-Lamee R, Thompson D, Dehbi HM, et al. Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial. Lancet. Jan 6 2018;391(10115):31-40. doi:10.1016/s0140-6736(17)32714-9
19. Al-Lamee R, Howard JP, Shun-Shin MJ, et al. Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Single-Vessel Coronary Artery Disease. Circulation. Oct 23 2018;138(17):1780-1792. doi:10.1161/circulationaha.118.033801
20. Botman CJ, Schonberger J, Koolen S, et al. Does stenosis severity of native vessels influence bypass graft patency? A prospective fractional flow reserve-guided study. Ann Thorac Surg. Jun 2007;83(6):2093-7. doi:10.1016/j.athoracsur.2007.01.027
21. Toth GG, De Bruyne B, Kala P, et al. Graft patency after FFR-guided versus angiography-guided coronary artery bypass grafting: the GRAFFITI trial. EuroIntervention. Dec 6 2019;15(11):e999-e1005. doi:10.4244/eij-d-19-00463
22. Thuesen AL, Riber LP, Veien KT, et al. Fractional Flow Reserve Versus Angiographically-Guided Coronary Artery Bypass Grafting. J Am Coll Cardiol. Dec 4 2018;72(22):2732-2743. doi:10.1016/j.jacc.2018.09.043
23. Fournier S, Toth GG, De Bruyne B, et al. Six-Year Follow-Up of Fractional Flow Reserve-Guided Versus Angiography-Guided Coronary Artery Bypass Graft Surgery. Circ Cardiovasc Interv. Jun 2018;11(6):e006368. doi:10.1161/CIRCINTERVENTIONS.117.006368
24. Glineur D, Grau JB, Etienne P-Y, et al. Impact of preoperative fractional flow reserve on arterial bypass graft anastomotic function: the IMPAG trial. European Heart Journal. 2019;40(29):2421-2428. doi:10.1093/eurheartj/ehz329
25. Schwartz L, Bertolet M, Feit F, et al. Impact of completeness of revascularization on long-term cardiovascular outcomes in patients with type 2 diabetes mellitus: results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D). Circ Cardiovasc Interv. Apr 2012;5(2):166-73. doi:10.1161/circinterventions.111.963512
26. Farooq V, Serruys PW, Garcia-Garcia HM, et al. The negative impact of incomplete angiographic revascularization on clinical outcomes and its association with total occlusions: the SYNTAX (Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) trial. J Am Coll Cardiol. Jan 22 2013;61(3):282-94. doi:10.1016/j.jacc.2012.10.017
27. Bangalore S, Guo Y, Samadashvili Z, Hannan EL. Outcomes With Complete Versus Incomplete Revascularization in Patients With Multivessel Coronary Disease Undergoing Percutaneous Coronary Intervention With Everolimus Eluting Stents. Am J Cardiol. Feb 1 2020;125(3):362-369. doi:10.1016/j.amjcard.2019.10.022
28. Ando T, Takagi H, Grines CL. Complete versus incomplete revascularization with drug-eluting stents for multi-vessel disease in stable, unstable angina or non-ST-segment elevation myocardial infarction: A meta-analysis. J Interv Cardiol. Aug 2017;30(4):309-317. doi:10.1111/joic.12390
29. Ahn JM, Park DW, Lee CW, et al. Comparison of Stenting Versus Bypass Surgery According to the Completeness of Revascularization in Severe Coronary Artery Disease: Patient-Level Pooled Analysis of the SYNTAX, PRECOMBAT, and BEST Trials. JACC Cardiovasc Interv. Jul 24 2017;10(14):1415-1424. doi:10.1016/j.jcin.2017.04.037
30. Head SJ, Davierwala PM, Serruys PW, et al. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial. Eur Heart J. Oct 21 2014;35(40):2821-30. doi:10.1093/eurheartj/ehu213
31. Head SJ, Holmes DR, Jr., Mack MJ, et al. Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries. JACC Cardiovasc Interv. Jun 2012;5(6):618-25. doi:10.1016/j.jcin.2012.02.013
32. Redfors B, Stone GW, Alexander JH, et al. Outcomes According to Coronary Revascularization Modality in the ISCHEMIA Trial. J Am Coll Cardiol. Feb 6 2024;83(5):549-558. doi:10.1016/j.jacc.2023.11.002
33. Lopes RD, Mehta RH, Hafley GE, et al. Relationship between vein graft failure and subsequent clinical outcomes after coronary artery bypass surgery. Circulation. Feb 14 2012;125(6):749-56. doi:10.1161/CIRCULATIONAHA.111.040311
34. Shih E, Squiers JJ, Banwait JK, et al. Vein Graft Use and Long-Term Survival Following Coronary Bypass Grafting. J Am Coll Cardiol. Feb 28 2023;81(8):713-725. doi:10.1016/j.jacc.2022.11.054
35. Marshall MV, Rasmussen JC, Tan IC, et al. Near-Infrared Fluorescence Imaging in Humans with Indocyanine Green: A Review and Update. Open Surg Oncol J. 2010;2(2):12-25. doi:10.2174/1876504101002010012
36. Ferguson TB, Jr., Chen C, Babb JD, Efird JT, Daggubati R, Cahill JM. Fractional flow reserve-guided coronary artery bypass grafting: can intraoperative physiologic imaging guide decision making? J Thorac Cardiovasc Surg. Oct 2013;146(4):824-835 e1. doi:10.1016/j.jtcvs.2013.06.026
37. Buch AN, Alwair H, Cook CM, et al. Immediate impact of coronary artery bypass graft surgery on regional myocardial perfusion: Results from the Collaborative Pilot Study to Determine the Correlation Between Intraoperative Observations Using Spy Near-Infrared Imaging and Cardiac Catheterization Laboratory Physiological Assessment of Lesion Severity. JTCVS Open. 2022;12:158-176. doi:10.1016/j.xjon.2022.08.012
2. Farkouh ME, Domanski M, Sleeper LA, et al. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med. Dec 20 2012;367(25):2375-84. doi:10.1056/NEJMoa1211585
3. Giustino G, Serruys PW, Sabik JF, 3rd, et al. Mortality After Repeat Revascularization Following PCI or CABG for Left Main Disease: The EXCEL Trial. JACC Cardiovasc Interv. Feb 10 2020;13(3):375-387. doi:10.1016/j.jcin.2019.09.019
4. Maron DJ, Hochman JS, Reynolds HR, et al. Initial Invasive or Conservative Strategy for Stable Coronary Disease. N Engl J Med. Apr 9 2020;382(15):1395-1407. doi:10.1056/NEJMoa1915922
5. Esper RB, Farkouh ME, Ribeiro EE, et al. SYNTAX Score in Patients With Diabetes Undergoing Coronary Revascularization in the FREEDOM Trial. J Am Coll Cardiol. Dec 11 2018;72(23 Pt A):2826-2837. doi:10.1016/j.jacc.2018.09.046
6. Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. Apr 12 2007;356(15):1503-16. doi:10.1056/NEJMoa070829
7. Parisi AF, Folland ED, Hartigan P. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators. N Engl J Med. Jan 2 1992;326(1):10-6. doi:10.1056/nejm199201023260102
8. Spertus JA, Jones PG, Maron DJ, et al. Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease. N Engl J Med. Apr 9 2020;382(15):1408-1419. doi:10.1056/NEJMoa1916370
9. Samadashvili Z, Sundt TM, 3rd, Wechsler A, et al. Multiple Versus Single Arterial Coronary Bypass Graft Surgery for Multivessel Disease. J Am Coll Cardiol. Sep 10 2019;74(10):1275-1285. doi:10.1016/j.jacc.2019.06.067
10. Pu A, Ding L, Shin J, et al. Long-term Outcomes of Multiple Arterial Coronary Artery Bypass Grafting: A Population-Based Study of Patients in British Columbia, Canada. JAMA Cardiol. Nov 1 2017;2(11):1187-1196. doi:10.1001/jamacardio.2017.3705
11. Gaudino M, Benedetto U, Fremes S, et al. Association of Radial Artery Graft vs Saphenous Vein Graft With Long-term Cardiovascular Outcomes Among Patients Undergoing Coronary Artery Bypass Grafting: A Systematic Review and Meta-analysis. Jama. Jul 14 2020;324(2):179-187. doi:10.1001/jama.2020.8228
12. Gaudino M, Chadow D, Rahouma M, et al. Operative Outcomes of Women Undergoing Coronary Artery Bypass Surgery in the US, 2011 to 2020. JAMA Surgery. 2023;158(5):494-502. doi:10.1001/jamasurg.2022.8156
13. Tonino PA, De Bruyne B, Pijls NH, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. Jan 15 2009;360(3):213-24. doi:10.1056/NEJMoa0807611
14. van Nunen LX, Zimmermann FM, Tonino PA, et al. Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial. Lancet. Nov 7 2015;386(10006):1853-60. doi:10.1016/s0140-6736(15)00057-4
15. Sels JW, Tonino PA, Siebert U, et al. Fractional flow reserve in unstable angina and non-ST-segment elevation myocardial infarction experience from the FAME (Fractional flow reserve versus Angiography for Multivessel Evaluation) study. JACC Cardiovasc Interv. Nov 2011;4(11):1183-9. doi:10.1016/j.jcin.2011.08.008
16. Puymirat E, Cayla G, Simon T, et al. Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction. N Engl J Med. Jul 22 2021;385(4):297-308. doi:10.1056/NEJMoa2104650
17. Al-Lamee RK, Shun-Shin MJ, Howard JP, et al. Dobutamine Stress Echocardiography Ischemia as a Predictor of the Placebo-Controlled Efficacy of Percutaneous Coronary Intervention in Stable Coronary Artery Disease: The Stress Echocardiography-Stratified Analysis of ORBITA. Circulation. Nov 11 2019; doi:10.1161/ circulationaha.119.042918
18. Al-Lamee R, Thompson D, Dehbi HM, et al. Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial. Lancet. Jan 6 2018;391(10115):31-40. doi:10.1016/s0140-6736(17)32714-9
19. Al-Lamee R, Howard JP, Shun-Shin MJ, et al. Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Single-Vessel Coronary Artery Disease. Circulation. Oct 23 2018;138(17):1780-1792. doi:10.1161/circulationaha.118.033801
20. Botman CJ, Schonberger J, Koolen S, et al. Does stenosis severity of native vessels influence bypass graft patency? A prospective fractional flow reserve-guided study. Ann Thorac Surg. Jun 2007;83(6):2093-7. doi:10.1016/j.athoracsur.2007.01.027
21. Toth GG, De Bruyne B, Kala P, et al. Graft patency after FFR-guided versus angiography-guided coronary artery bypass grafting: the GRAFFITI trial. EuroIntervention. Dec 6 2019;15(11):e999-e1005. doi:10.4244/eij-d-19-00463
22. Thuesen AL, Riber LP, Veien KT, et al. Fractional Flow Reserve Versus Angiographically-Guided Coronary Artery Bypass Grafting. J Am Coll Cardiol. Dec 4 2018;72(22):2732-2743. doi:10.1016/j.jacc.2018.09.043
23. Fournier S, Toth GG, De Bruyne B, et al. Six-Year Follow-Up of Fractional Flow Reserve-Guided Versus Angiography-Guided Coronary Artery Bypass Graft Surgery. Circ Cardiovasc Interv. Jun 2018;11(6):e006368. doi:10.1161/CIRCINTERVENTIONS.117.006368
24. Glineur D, Grau JB, Etienne P-Y, et al. Impact of preoperative fractional flow reserve on arterial bypass graft anastomotic function: the IMPAG trial. European Heart Journal. 2019;40(29):2421-2428. doi:10.1093/eurheartj/ehz329
25. Schwartz L, Bertolet M, Feit F, et al. Impact of completeness of revascularization on long-term cardiovascular outcomes in patients with type 2 diabetes mellitus: results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D). Circ Cardiovasc Interv. Apr 2012;5(2):166-73. doi:10.1161/circinterventions.111.963512
26. Farooq V, Serruys PW, Garcia-Garcia HM, et al. The negative impact of incomplete angiographic revascularization on clinical outcomes and its association with total occlusions: the SYNTAX (Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) trial. J Am Coll Cardiol. Jan 22 2013;61(3):282-94. doi:10.1016/j.jacc.2012.10.017
27. Bangalore S, Guo Y, Samadashvili Z, Hannan EL. Outcomes With Complete Versus Incomplete Revascularization in Patients With Multivessel Coronary Disease Undergoing Percutaneous Coronary Intervention With Everolimus Eluting Stents. Am J Cardiol. Feb 1 2020;125(3):362-369. doi:10.1016/j.amjcard.2019.10.022
28. Ando T, Takagi H, Grines CL. Complete versus incomplete revascularization with drug-eluting stents for multi-vessel disease in stable, unstable angina or non-ST-segment elevation myocardial infarction: A meta-analysis. J Interv Cardiol. Aug 2017;30(4):309-317. doi:10.1111/joic.12390
29. Ahn JM, Park DW, Lee CW, et al. Comparison of Stenting Versus Bypass Surgery According to the Completeness of Revascularization in Severe Coronary Artery Disease: Patient-Level Pooled Analysis of the SYNTAX, PRECOMBAT, and BEST Trials. JACC Cardiovasc Interv. Jul 24 2017;10(14):1415-1424. doi:10.1016/j.jcin.2017.04.037
30. Head SJ, Davierwala PM, Serruys PW, et al. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial. Eur Heart J. Oct 21 2014;35(40):2821-30. doi:10.1093/eurheartj/ehu213
31. Head SJ, Holmes DR, Jr., Mack MJ, et al. Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries. JACC Cardiovasc Interv. Jun 2012;5(6):618-25. doi:10.1016/j.jcin.2012.02.013
32. Redfors B, Stone GW, Alexander JH, et al. Outcomes According to Coronary Revascularization Modality in the ISCHEMIA Trial. J Am Coll Cardiol. Feb 6 2024;83(5):549-558. doi:10.1016/j.jacc.2023.11.002
33. Lopes RD, Mehta RH, Hafley GE, et al. Relationship between vein graft failure and subsequent clinical outcomes after coronary artery bypass surgery. Circulation. Feb 14 2012;125(6):749-56. doi:10.1161/CIRCULATIONAHA.111.040311
34. Shih E, Squiers JJ, Banwait JK, et al. Vein Graft Use and Long-Term Survival Following Coronary Bypass Grafting. J Am Coll Cardiol. Feb 28 2023;81(8):713-725. doi:10.1016/j.jacc.2022.11.054
35. Marshall MV, Rasmussen JC, Tan IC, et al. Near-Infrared Fluorescence Imaging in Humans with Indocyanine Green: A Review and Update. Open Surg Oncol J. 2010;2(2):12-25. doi:10.2174/1876504101002010012
36. Ferguson TB, Jr., Chen C, Babb JD, Efird JT, Daggubati R, Cahill JM. Fractional flow reserve-guided coronary artery bypass grafting: can intraoperative physiologic imaging guide decision making? J Thorac Cardiovasc Surg. Oct 2013;146(4):824-835 e1. doi:10.1016/j.jtcvs.2013.06.026
37. Buch AN, Alwair H, Cook CM, et al. Immediate impact of coronary artery bypass graft surgery on regional myocardial perfusion: Results from the Collaborative Pilot Study to Determine the Correlation Between Intraoperative Observations Using Spy Near-Infrared Imaging and Cardiac Catheterization Laboratory Physiological Assessment of Lesion Severity. JTCVS Open. 2022;12:158-176. doi:10.1016/j.xjon.2022.08.012